{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiggnow2gvksuffqvpngijgna7c2ti23rfxvreqfyljcznbgjyqjwq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mnnorvjxdj62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifg2xo65zhtojqqwulrk3zdlxta66pkz3a452mjngor2zkxn6yfea"
    },
    "mimeType": "image/jpeg",
    "size": 54748
  },
  "path": "/2026/06/06/triple-g-safety-data-monthly-obesity-drug-ada-in-30/?utm_campaign=rss",
  "publishedAt": "2026-06-06T20:54:24.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Newsletters",
    "chronic disease",
    "diabetes",
    "STAT+"
  ],
  "textContent": "You're reading the web edition of STAT's ADA in 30 Seconds, from the American Diabetes Association's annual conference in New Orleans.",
  "title": "STAT+: Triple hormone receptors, a monthly obesity drug, and a bittersweet ending",
  "updatedAt": "2026-06-06T20:54:29.000Z"
}